Anglo-Swiss pharmaceutical firm AstraZeneca is pushing further into the oncology market by partnering with Japanese cancer drugmaker Daiichi Sankyo

Scientific instruments maker Thermo Fisher has acquired a Dutch drug company in new push towards biopharma manufacturing